Phase II trial of dose dense docetaxel followed by FEC100 as neoadjuvant chemotherapy in patients with operable breast cancer

The aim of this study was to evaluate the efficacy and safety profile of 4 dose-dense cycles of docetaxel followed by 3 cycles of FEC100 neoadjuvant chemotherapy in patients with operable advanced breast cancer. Women were treated by 4 cycles of 100 mg/m² docetaxel every 2 weeks, followed by 3 cycle...

Ausführliche Beschreibung